$198 Million is the total value of First Light Asset Management, LLC's 67 reported holdings in Q1 2016. The portfolio turnover from Q4 2015 to Q1 2016 was 12.3% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| NEO | Buy | NEOGENOMICS INC | $20,917,000 | -14.0% | 3,103,386 | +0.4% | 10.55% | +3.6% |
| ATRC | Buy | ATRICURE INC | $15,605,000 | -24.6% | 927,210 | +0.5% | 7.87% | -9.2% |
| AKRXQ | Buy | AKORN INC | $8,436,000 | -33.8% | 358,525 | +5.0% | 4.26% | -20.2% |
| ENZ | Sell | ENZO BIOCHEM INC | $7,880,000 | -23.5% | 1,731,786 | -24.3% | 3.98% | -7.8% |
| ENTL | Buy | ENTELLUS MEDICAL INC | $7,224,000 | +9.4% | 397,141 | +1.4% | 3.64% | +31.8% |
| AMED | Buy | AMEDISYS INC | $7,097,000 | +23.4% | 146,818 | +0.4% | 3.58% | +48.6% |
| HBIO | Buy | HARVARD BIOSCIENCE INC | $6,494,000 | -8.3% | 2,150,193 | +5.4% | 3.28% | +10.5% |
| LHCG | Buy | LHC GROUP INC | $6,135,000 | -16.5% | 172,537 | +6.4% | 3.10% | +0.6% |
| LMAT | Buy | LEMAITRE VASCULAR INC | $6,089,000 | -7.6% | 392,317 | +2.7% | 3.07% | +11.3% |
| LGND | Sell | LIGAND PHARMACEUTICALS INC | $6,073,000 | -1.4% | 56,711 | -0.2% | 3.06% | +18.8% |
| OXFD | Buy | OXFORD IMMUNOTEC GLOBAL PLC | $5,418,000 | -5.9% | 546,724 | +9.2% | 2.73% | +13.3% |
| TLGT | Buy | TELIGENT INC | $4,993,000 | -43.8% | 1,019,059 | +2.0% | 2.52% | -32.3% |
| EVHC | Buy | ENVISION HEALTHCARE HOLDINGS INC | $4,703,000 | +36.0% | 230,558 | +73.1% | 2.37% | +63.8% |
| LDRH | Buy | LDR HOLDING CORPORATION | $4,586,000 | +3.1% | 179,916 | +1.6% | 2.31% | +24.3% |
| ELGX | Sell | ENDOLOGIX INC | $4,432,000 | -36.3% | 530,129 | -24.6% | 2.24% | -23.3% |
| BEAT | New | BIOTELEMETRY INC | $4,263,000 | – | 364,978 | +100.0% | 2.15% | – |
| SPNC | Buy | SPECTRANETICS CORP | $4,112,000 | +2.7% | 283,220 | +6.6% | 2.07% | +23.7% |
| RTIX | Sell | RTI BIOLOGICS INC | $4,016,000 | +0.6% | 1,004,076 | -0.2% | 2.03% | +21.2% |
| MDCO | Buy | MEDICINES COMPANY | $3,963,000 | +13.3% | 124,740 | +33.2% | 2.00% | +36.5% |
| NXTM | Buy | NXSTAGE MEDICAL INC | $3,866,000 | -29.7% | 257,927 | +2.7% | 1.95% | -15.4% |
| IMMU | Buy | IMMUNOMEDICS INC | $3,859,000 | +47.7% | 1,543,542 | +81.4% | 1.95% | +78.0% |
| OFIX | New | ORTHOFIX INTERNATIONAL NV | $3,536,000 | – | 85,153 | +100.0% | 1.78% | – |
| ANGO | Buy | ANGIODYNAMICS INC | $3,357,000 | +5.5% | 273,122 | +4.2% | 1.69% | +27.1% |
| VCYT | Buy | VERACYTE INC | $3,005,000 | -21.6% | 556,465 | +4.5% | 1.52% | -5.6% |
| DOC | Sell | PHYSICIANS REALTY TRUST | $2,940,000 | -45.1% | 158,222 | -50.2% | 1.48% | -33.9% |
| BLUE | Buy | BLUEBIRD BIO INC | $2,895,000 | -31.8% | 68,107 | +3.0% | 1.46% | -17.9% |
| HSTM | Sell | HEALTHSTREAM INC | $2,575,000 | +0.0% | 116,568 | -0.4% | 1.30% | +20.5% |
| QDEL | Sell | QUIDEL CORP | $2,560,000 | -38.1% | 148,337 | -24.0% | 1.29% | -25.5% |
| STRM | Buy | STREAMLINE HEALTH SOLUTIONS | $2,477,000 | +1.0% | 1,756,388 | +1.0% | 1.25% | +21.7% |
| PETX | Buy | ARATANA THERAPEUTICS INC | $2,473,000 | +12.2% | 448,006 | +13.4% | 1.25% | +35.2% |
| ARWR | Buy | ARROWHEAD RESEARCH CORP | $2,369,000 | -16.8% | 491,574 | +6.1% | 1.20% | +0.2% |
| TEAR | Sell | TEARLAB CORP | $2,360,000 | -54.9% | 3,746,163 | -0.4% | 1.19% | -45.6% |
| TECH | Sell | BIO TECHNE CORP | $2,316,000 | +4.8% | 24,506 | -0.2% | 1.17% | +26.1% |
| CYNA | Sell | CYNAPSUS THERAPEUTICS INC | $2,285,000 | -49.5% | 191,980 | -35.2% | 1.15% | -39.2% |
| INSM | Sell | INSMED INC | $2,254,000 | -50.8% | 177,930 | -29.5% | 1.14% | -40.8% |
| ALKS | Sell | ALKERMES PLC | $2,162,000 | -57.1% | 63,228 | -0.4% | 1.09% | -48.3% |
| CPHD | Buy | CEPHEID | $2,113,000 | -3.1% | 63,338 | +6.1% | 1.07% | +16.8% |
| VRTX | Sell | VERTEX PHARMACEUTICALS INC | $1,930,000 | -36.9% | 24,276 | -0.2% | 0.97% | -24.0% |
| BMRN | Sell | BIOMARIN PHARMACEUTICAL INC | $1,555,000 | -21.5% | 18,855 | -0.2% | 0.78% | -5.4% |
| ARRY | Sell | ARRAY BIOPHARMA INC | $1,552,000 | -30.7% | 526,270 | -0.8% | 0.78% | -16.4% |
| CLDX | Buy | CELLDEX THERAPEUTICS INC | $797,000 | -75.6% | 210,807 | +1.2% | 0.40% | -70.6% |
| HUM | HUMANA INC | $648,000 | +2.5% | 3,540 | 0.0% | 0.33% | +23.4% | |
| BIOS | Buy | BIOSCRIPT INC | $647,000 | +31.2% | 302,110 | +7.3% | 0.33% | +58.3% |
| AET | AETNA INC NEW | $586,000 | +3.9% | 5,215 | 0.0% | 0.30% | +25.4% | |
| ANTM | ANTHEM INC COM | $569,000 | -0.4% | 4,095 | 0.0% | 0.29% | +20.1% | |
| AGN | ALLERGAN PLC SHS | $545,000 | -14.3% | 2,035 | 0.0% | 0.28% | +3.4% | |
| BMY | BRISTOL MYERS SQUIBB CO | $530,000 | -7.0% | 8,290 | 0.0% | 0.27% | +11.7% | |
| BDX | BECTON DICKINSON AND CO | $515,000 | -1.5% | 3,395 | 0.0% | 0.26% | +18.7% | |
| MYL | MYLAN N V | $453,000 | -14.4% | 9,775 | 0.0% | 0.23% | +3.2% | |
| STE | New | STERIS CORP | $450,000 | – | 6,330 | +100.0% | 0.23% | – |
| NVS | NOVARTIS A G | $440,000 | -15.7% | 6,070 | 0.0% | 0.22% | +1.4% | |
| CELG | CELGENE CORP | $428,000 | -16.6% | 4,280 | 0.0% | 0.22% | +0.5% | |
| UTHR | UNITED THERAPEUTICS CORP DEL | $426,000 | -28.8% | 3,820 | 0.0% | 0.22% | -14.0% | |
| JNJ | JOHNSON AND JOHNSON | $413,000 | +5.4% | 3,820 | 0.0% | 0.21% | +26.8% | |
| LLY | LILLY ELI AND CO | $396,000 | -14.5% | 5,495 | 0.0% | 0.20% | +3.1% | |
| AGRX | New | AGILE THERAPEUTICS | $382,000 | – | 61,469 | +100.0% | 0.19% | – |
| MRK | MERCK N CO INC NEW | $350,000 | +0.3% | 6,610 | 0.0% | 0.18% | +21.2% | |
| AMGN | AMGEN INC | $349,000 | -7.7% | 2,330 | 0.0% | 0.18% | +11.4% | |
| STJ | ST JUDE MED INC | $333,000 | -11.0% | 6,055 | 0.0% | 0.17% | +7.0% | |
| AZN | ASTRAZENECA PLC | $320,000 | -17.1% | 11,360 | 0.0% | 0.16% | -0.6% | |
| PFE | PFIZER INC | $312,000 | -8.2% | 10,520 | 0.0% | 0.16% | +10.6% | |
| MYGN | MYRIAD GENETICS INC | $293,000 | -13.3% | 7,820 | 0.0% | 0.15% | +4.2% | |
| IRIX | New | IRIDEX CORP | $276,000 | – | 27,009 | +100.0% | 0.14% | – |
| BIO | BIO RAD LABS INC | $229,000 | -1.3% | 1,675 | 0.0% | 0.12% | +19.6% | |
| ENDP | ENDO INTL PLC | $230,000 | -54.0% | 8,161 | 0.0% | 0.12% | -44.5% | |
| SNY | SANOFI-SYNTHELABO | $228,000 | -5.8% | 5,680 | 0.0% | 0.12% | +13.9% | |
| A | AGILENT TECHNOLOGIES INC | $204,000 | -4.7% | 5,120 | 0.0% | 0.10% | +14.4% | |
| STE | Exit | STERIS CORP | $0 | – | -6,330 | -100.0% | -0.20% | – |
| KPTI | Exit | KARYOPHARM THERAPEUTICS INC | $0 | – | -152,765 | -100.0% | -0.85% | – |
| MDVN | Exit | MEDIVATION INC | $0 | – | -83,816 | -100.0% | -1.70% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2016-05-16
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ATRICURE INC | 40 | Q3 2023 | 9.7% |
| NEOGENOMICS INC | 40 | Q3 2023 | 10.6% |
| SANOFI-SYNTHELABO | 40 | Q3 2023 | 1.9% |
| JOHNSON & JOHNSON | 40 | Q3 2023 | 0.3% |
| PFIZER INC | 39 | Q2 2023 | 0.9% |
| BIOMARIN PHARMACEUTICAL INC | 36 | Q3 2023 | 1.6% |
| OMNICELL INC | 33 | Q3 2023 | 7.7% |
| QUIDEL CORP | 33 | Q4 2021 | 3.7% |
| NOVARTIS AG-SPONSORED ADR | 33 | Q3 2023 | 0.4% |
| MODEL N INC | 30 | Q3 2023 | 9.0% |
View First Light Asset Management, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| REATA PHARMACEUTICALS INC | May 15, 2023 | 1,290,193 | 3.9% |
| Axogen, Inc. | February 03, 2023 | 1,942,270 | 4.6% |
| MODEL N, INC. | February 03, 2023 | 1,845,134 | 4.9% |
| MEI Pharma, Inc.Sold out | May 31, 2022 | 0 | 0.0% |
| PROTHENA CORP PUBLIC LTD CO | March 01, 2022 | 1,805,038 | 3.9% |
| Intersect ENT, Inc. | February 14, 2022 | 1,375,210 | 4.1% |
| SeaSpine Holdings Corp | February 14, 2022 | 6,847,707 | 18.8% |
| Oxford Immunotec Global PLCSold out | February 10, 2021 | 0 | 0.0% |
| ENDOLOGIX INC /DE/ | February 14, 2020 | 816,236 | 4.6% |
| Nuvectra CorpSold out | February 14, 2020 | 0 | 0.0% |
View First Light Asset Management, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13D/A | 2024-04-09 |
| 4 | 2024-04-08 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13G | 2024-02-14 |
View First Light Asset Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.